Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes (Q43874043)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 January 2002

Language	Label	Description	Also known as
English	Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes	scientific article published on 31 January 2002

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes (English)

1 reference

Europe PubMed Central

27 November 2017

molecular chaperones

0 references

author name string

Michael J Piatelli

1

1 reference

Europe PubMed Central

27 November 2017

Cheryl Doughty

2

1 reference

Europe PubMed Central

27 November 2017

Thomas C Chiles

3

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

31 January 2002

1 reference

Europe PubMed Central

27 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

27 November 2017

277

1 reference

Europe PubMed Central

27 November 2017

14

1 reference

Europe PubMed Central

27 November 2017

12144-12150

1 reference

Europe PubMed Central

27 November 2017

Role of tyrosine kinases in lymphocyte activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Signal transduction from the B cell antigen-receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

D-type cyclin-dependent kinase activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

p21-containing cyclin kinases exist in both active and inactive states

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

The regulated expression of cell cycle-related proteins as B-lymphocytes enter and progress through the G1 cell cycle stage following delivery of complete versus partial activation stimuli

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Geldanamycin-induced destabilization of Raf-1 involves the proteasome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Multiple ras effector pathways contribute to G(1) cell cycle progression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Xid-like phenotypes: a B cell signalosome takes shape

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

BCR signals target p27Kip1 and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Signal transduction pathways that regulate the fate of B lymphocytes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200102200

21 January 2018

Identifiers

10.1074/JBC.M200102200

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43874043&oldid=2105509350"